Breaking News Instant updates and real-time market news.

SFTBF

SoftBank

$75.75

-0.168 (-0.22%)

, S

Sprint

$9.21

0.2123 (2.36%)

14:56
02/17/17
02/17
14:56
02/17/17
14:56

SoftBank to approach DT on Sprint, T-Mobile merger, Reuters reports

Japan's SoftBank (SFTBF) is prepared to relinquish control of Sprint (S) to Deutsche Telekom's (DTEGY) T-Mobile US (TMUS) to clinch a tie-up of the two U.S. wireless carriers, Reuters reports, citing people familiar with the matter. The Japanese company has not yet approached Deutsche Telekom to talk about any deal because the U.S. Federal Communications Commission has established strict anti-collusion rules that prohibit talks between rivals during an ongoing auction of airwaves, the report notes. After the auction comes to an end in April, the two companies are expected to start discussions, the report says. While SoftBank remains open to discussing other options, it is now willing to give up control of Sprint and keep a minority stake in a merger with T-Mobile, the report says. Shares of T-Mobile are up nearly 5% to $63.60 while Sprint shares are up a little over 4% to $9.38 in afternoon trading. Reference Link

SFTBF

SoftBank

$75.75

-0.168 (-0.22%)

S

Sprint

$9.21

0.2123 (2.36%)

DTEGY

Deutsche Telekom

$17.00

0.17 (1.01%)

TMUS

T-Mobile

$60.61

-0.685 (-1.12%)

  • 21

    Feb

  • 27

    Feb

  • 06

    Mar

SFTBF SoftBank
$75.75

-0.168 (-0.22%)

08/23/16
JPMS
08/23/16
UPGRADE
JPMS
Overweight
SoftBank upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Jun Tanabe upgraded SoftBank (SFTBF) to Overweight from Neutral and raised his price target on the stock to Y9,930 from Y6,500, citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business.
08/23/16
08/23/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Square (SQ) upgraded to Buy from Hold at Stifel with analyst Scott Devitt saying he now feels more confident in the company's growth and profitability outlook and its competitive position following three quarters of consistent execution. 2. BHP Billiton (BHP) upgraded to Buy from Hold at Jefferies with analyst Christopher LaFemina saying he believes fundamentals have "clearly improved," citing supply that has declined in most cases and demand that has stabilized. 3. SoftBank (SFTBF) upgraded to Overweight from Neutral at JPMorgan with analyst Jun Tanabe citing improved earnings at Sprint (S), the growth in value of its stake in Alibaba (BABA), and the stability of cash flow in its domestic mobile business. 4. Allscripts (MDRX) upgraded to Outperform from Market Perform at Leerink with analyst David Larsen saying he believes that the company's core fundamentals are improving "significantly." 5. Westlake Chemical (WLK) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying that the company's merger with Axiall (AXLL) "creates a new way to play chlor-alkali," as well as synergies. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/07/16
OPCO
12/07/16
NO CHANGE
Target $70
OPCO
Outperform
T-Mobile price target raised to $70 from $55 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for T-Mobile (TMUS) to $70 from $55 as he views it as the best way to play the deregulatory/technology driven consolidation. The analyst notes that President-Elect Trump met with Masayoshi Son of SoftBank (SFTBF), who agreed to invest $50B in the U.S. Horan believes the meeting will likely be a precursor to a Sprint (S)/T-Mobile/Dish (DISH) merger to create a discounted quad-play service company. The analyst reiterates an Outperform rating on T-Mobile' shares, and points out that the company has improved its network and taken share from AT&T (T)/Verizon (VZ).
S Sprint
$9.21

0.2123 (2.36%)

01/31/17
01/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. T-Mobile (TMUS) was initiated with a Buy at Evercore ISI, while Sprint (S), Verizon (VZ), and AT&T (T) were initiated with a Hold. 2. ViaSat (VSAT) initiated with an Outperform at William Blair. 3. Wyndham (WYN) initiated with a Neutral at Janney Capital. 4. ILG (ILG) initiated with a Buy at Janney Capital. 5. United Natural Foods (UNFI) initiated with a Neutral at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/30/17
EVER
01/30/17
INITIATION
Target $8
EVER
Hold
Sprint initiated with a Hold at Evercore ISI
Evercore ISI analyst Vijay Jayant started Sprint with a Hold rating $8 price target.
01/26/17
OPCO
01/26/17
NO CHANGE
OPCO
Verizon deal for Charter would make strategic sense, says Oppenheimer
Following multiple media reports indicating that Verizon (VZ) is exploring the potential for a combination with Charter Communications (CHTR), Oppenheimer analyst Timothy Horan said such a deal would make strategic sense as owning a cable company would allow Verizon to bundle wireless and wireline to create a "lower-cost and better" 5G offering. Valuation would be a major sticking point, however, Horan tells investors. If such a deal were to happen, it would be "very positive" for T-Mobile (TMUS) as it would make a theoretical deal with Sprint (S) easier to get done or it could make Comcast (CMCSA) more likely to look at a takeover of the wireless company, added the analyst. However, DISH's (DISH) strategic options may be more limited following a Verizon-Charter tie-up, Horan added.
01/25/17
SBSH
01/25/17
NO CHANGE
Target $94
SBSH
Buy
DISH removed from Focus List at Citi
Citi analyst Jason Bazinet removed DISH Network (DISH) from his firm's Focus List but keeps a Buy rating on the shares with a $94 price target. Under a Trump administration, Verizon (VZ) may have more options to acquire spectrum outside of acquiring DISH, Bazinet tells investors in a research note. Divestitures from a potential Sprint (S), T-Mobile (TMUS) merger could allow Verizon to acquire spectrum, the analyst contends.
DTEGY Deutsche Telekom
$17.00

0.17 (1.01%)

01/23/17
JPMS
01/23/17
NO CHANGE
JPMS
JPMorgan says odds of T-Mobile, Sprint merger have 'increased dramatically'
JPMorgan analyst Philip Cusick believes T-Mobile (TMUS), Sprint (S) and DISH (DISH) are in play and that a combination of any of them could happen. In addition, each of the three companies could become targets for larger wireless players, domestic cable companies, Internet giants and foreign buyers, Cusick tells investors in a research note. He thinks the likelihood for a Sprint and T-Mobile tie-up in the near term has "increased dramatically" since September, from 10% to over 35%, including now a greater than 50% chance of announcement and 70% chance of approval if announced. Parents Softbank (SFTBY) and Deutsche Telekom (DTEGY) have increased their preference for a deal in the last six months and that the value of $5B of annual synergies "is enough to smooth over most disagreements on relative value," Cusick contends. He sees the most likely case as Sprint/Softbank buying T-Mobile, but feels a more even merger or even Deutsche Telekom/T-Mobile paying a premium to retain a majority of the combined company is possible.
01/23/17
JPMS
01/23/17
UPGRADE
JPMS
Overweight
Deutsche Telekom upgraded to Overweight from Neutral at JPMorgan
Price target EUR 19.50.
06/16/16
JEFF
06/16/16
DOWNGRADE
JEFF
Underperform
Deutsche Telekom downgraded to Underperform from Hold at Jefferies
Jefferies analyst Ulrich Rathe downgraded Deutsche Telekom to Underperform with a EUR 12.10 price target.
TMUS T-Mobile
$60.61

-0.685 (-1.12%)

02/15/17
JEFF
02/15/17
NO CHANGE
Target $71
JEFF
Buy
T-Mobile price target raised to $71 from $59 at Jefferies
Jefferies analyst Mike McCormack raised his price target for T-Mobile to $71 saying the company's strong growth is set to continue following its Q4 results. The analyst expects both the net adds and cash EBITDA outlooks for 2017 to move higher. He sees, however, M&A speculation dictating near term share performance. McCormack removed T-Mobile from his firm's Franchise Pick list but keeps a Buy rating on the name.
02/15/17
RBCM
02/15/17
NO CHANGE
RBCM
T-Mobile 2017 guidance "conservative," says RBC Capital
RBC Capital analyst Jonathan Atkin says that T-Mobile reported "solid" Q4 results. He thinks that the company's 2017 guidance is "conservative" and could rise throughout the year. Atkin keeps an Outperform rating on the stock.
02/07/17
NOMU
02/07/17
NO CHANGE
Target $62
NOMU
Neutral
T-Mobile price target raised to $62 from $46 at Nomura
Nomura analyst Jeffrey Kvaal raised Neutral rated T-Mobile's price target to $62 from $46 following the release of preliminary Q4 subscriber metrics marked by improved visibility and sustained net add trajectory. Kvaal believes the incumbents remain unwilling to sacrifice margin to compete with the success of unlimited data plans. He assigned a modest premium to a potential M&A scenario, as he is less optimistic than most observers.

TODAY'S FREE FLY STORIES

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:13
12/15/17
12/15
05:13
12/15/17
05:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRC

First Republic

$88.54

-0.27 (-0.30%)

05:11
12/15/17
12/15
05:11
12/15/17
05:11
Downgrade
First Republic rating change  »

First Republic downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSRO

Tesaro

$83.87

0.84 (1.01%)

05:10
12/15/17
12/15
05:10
12/15/17
05:10
Hot Stocks
Tesaro announces availability of Zejula in Germany »

Tesaro announced today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCM

Hutchison China MediTech

$31.11

0.05 (0.16%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Hot Stocks
Hutchison China MediTech initiates fruquintinib U.S. clinical trials »

Hutchison China MediTech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

, CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

05:09
12/15/17
12/15
05:09
12/15/17
05:09
Recommendations
Snyder's-Lance, Campbell Soup analyst commentary  »

Snyder's-Lance worth…

LNCE

Snyder's-Lance

$44.42

5.01 (12.71%)

CPB

Campbell Soup

$48.56

-0.63 (-1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$57.31

-0.38 (-0.66%)

05:07
12/15/17
12/15
05:07
12/15/17
05:07
Hot Stocks
CSX announces medical leave of CEO, COO James Foote named acting CEO »

CSX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:03
12/15/17
12/15
05:03
12/15/17
05:03
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$175.00

-1.83 (-1.03%)

05:00
12/15/17
12/15
05:00
12/15/17
05:00
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SON

Sonoco Products

$53.13

-0.6 (-1.12%)

04:59
12/15/17
12/15
04:59
12/15/17
04:59
Upgrade
Sonoco Products rating change  »

Sonoco Products upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

, AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

04:58
12/15/17
12/15
04:58
12/15/17
04:58
Upgrade
Sealed Air, Avery Dennison rating change  »

Sealed Air upgraded to…

SEE

Sealed Air

$48.03

-0.22 (-0.46%)

AVY

Avery Dennison

$114.28

-0.09 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$10.80

-0.1 (-0.92%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Initiation
Hi-Crush Partners initiated  »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MET

MetLife

$52.49

-0.35 (-0.66%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
MetLife to hold a conference call »

Investor outlook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

  • 12

    Jun

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

November Industrial…

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Breaking General news story  »

Week of 12/15…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

, FOXA

21st Century Fox

$34.88

2.13 (6.50%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Cable, Media &…

FOX

21st Century Fox

$34.22

1.88 (5.81%)

FOXA

21st Century Fox

$34.88

2.13 (6.50%)

DIS

Disney

$110.57

2.96 (2.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
General news
Industrial Production to be reported at 09:15 »

November Industrial…

ADRNY

Ahold Delhaize

$21.69

-0.14 (-0.64%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Ahold Delhaize management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

BASFY

BASF

$27.57

-0.17 (-0.61%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
BASF management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

CUTR

Cutera

$47.20

-1.3 (-2.68%)

, TESO

Tesco

$3.70

-0.25 (-6.33%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Hot Stocks
Cutera to replace Tesco in S&P 600 at open on 12/15 »

MidCap 400 constituent…

CUTR

Cutera

$47.20

-1.3 (-2.68%)

TESO

Tesco

$3.70

-0.25 (-6.33%)

NBR

Nabors Industries

$5.58

-0.23 (-3.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

RCKZF

Rocket Internet

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Rocket Internet management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

AGYS

Agilysys

$12.35

0.05 (0.41%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Agilysys management to meet with Sidoti »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

PJT

PJT Partners

$44.10

-0.24 (-0.54%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
PJT Partners management to meet with Sandler O'Neill »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Jefferies software/cybersecurity analyst holds analyst/industry conference call »

Analyst DiFucci, along…

ROG

Rogers Corporation

$156.57

-1.57 (-0.99%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Rogers Corporation management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

JAGX

Jaguar Health

$0.13

0.0068 (5.52%)

04:55
12/15/17
12/15
04:55
12/15/17
04:55
Conference/Events
Jaguar Health to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.